HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Injury- and inflammation-driven skin fibrosis: The paradigm of epidermolysis bullosa.

Abstract
Genetic or acquired destabilization of the dermal extracellular matrix evokes injury- and inflammation-driven progressive soft tissue fibrosis. Dystrophic epidermolysis bullosa (DEB), a heritable human skin fragility disorder, is a paradigmatic disease to investigate these processes. Studies of DEB have generated abundant new information on cellular and molecular mechanisms at play in skin fibrosis which are not only limited to intractable diseases, but also applicable to some of the most common acquired conditions. Here, we discuss recent advances in understanding the biological and mechanical mechanisms driving the dermal fibrosis in DEB. Much of this progress is owed to the implementation of cell and tissue omics studies, which we pay special attention to. Based on the novel findings and increased understanding of the disease mechanisms in DEB, translational aspects and future therapeutic perspectives are emerging.
AuthorsAlexander Nyström, Leena Bruckner-Tuderman
JournalMatrix biology : journal of the International Society for Matrix Biology (Matrix Biol) Vol. 68-69 Pg. 547-560 (Aug 2018) ISSN: 1569-1802 [Electronic] Netherlands
PMID29391280 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
CopyrightCopyright © 2018 Elsevier B.V. All rights reserved.
Chemical References
  • COL7A1 protein, human
  • Collagen Type VII
Topics
  • Animals
  • Collagen Type VII (genetics)
  • Disease Models, Animal
  • Epidermolysis Bullosa Dystrophica (genetics, metabolism, pathology)
  • Extracellular Matrix (genetics)
  • Gene Expression Profiling
  • Gene Knockout Techniques
  • Humans
  • Mice
  • Mice, Transgenic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: